Advertisement

Topics

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. Company Profile

20:30 EDT 22nd September 2017 | BioPortfolio

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3


News Articles [8860 Associated News Articles listed on BioPortfolio]

Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 3, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at two healthcare conferences in November. Credit Suisse 2011 A...

Bayer Healthcare Pharmaceuticals Strategy, SWOT and Corporate Finance Report [Updated: 05052017] Prices from USD $175

Bayer Healthcare Pharmaceuticals Strategy, SWOT and Corporate Finance ReportSummaryBayer Healthcare Pharmaceuticals Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company ...

Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results Teleconference and Webcast

SAN FRANCISCO, Feb. 9, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will host a webcast and teleconference with management to discuss fourth quarter and full ...

Bayer Healthcare Pharmaceuticals Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 01052017] Prices from USD $350

Bayer Healthcare Pharmaceuticals Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Bayer Healthcare Pharmaceuticals Mergers Acquisitions MA, Partnerships Al...

Bayer Healthcare Pharmaceuticals Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 14062017] Prices from USD $350

Bayer Healthcare Pharmaceuticals Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Bayer Healthcare Pharmaceuticals Mergers Acquisitions MA, Partnerships Al...

Bayer Initiates Expanded Access Program for Investigational Compound Radium-223 Chloride

WAYNE, N.J., Feb. 2, 2012 /PRNewswire/ -- Bayer HealthCare, LLC today announced that the U.S. Food and Drug Administration agreed that Bayer can proceed with its expanded access program ...

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.

Amylin Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference

SAN DIEGO, Feb. 9, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Leerink Swann 2012 Global Healthcare Conference in New York on Thursday, February 16, 2012...

PubMed Articles [1574 Associated PubMed Articles listed on BioPortfolio]

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.

Antibiotics and antidepressants are among the most successful drugs used for human therapy. Their concentration in influent on WWTP is relative high and there can be removed by biodegradation or sorpt...

Clinical Trials [1011 Associated Clinical Trials listed on BioPortfolio]

A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-Fasting Conditions

The purpose of this study is compare the relative bioavailability of Nifedipine ER tablets 60 mg by Abrica Pharmaceuticals LLLP with that of ADALAT® CC Extended Release Tablets 60 mg by ...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Companies [3533 Associated Companies listed on BioPortfolio]

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc.

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3

Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developi...

Bayer Animal Health

Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combine...

Onyx Pharmaceuticals

Onyx Pharmaceuticals, Inc. is engaged in the discovery and development of novel therapeutics based upon the genetics of human disease, with an emphasis on cancer. The Company's strategy is to capitali...

Bayer HealthCare Pharmaceuticals, Inc.

More Information about "Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record